The Friedrich Loeffler Institute in Germany has announced the successful testing of an experimental mRNA vaccine against foot-and-mouth disease (FMD), which could improve virus management. This vaccine uses fragments of the virus's genetic code, avoiding the need to manipulate live virus, making it safer. In tests, vaccinated cows showed no symptoms and shed less virus than unvaccinated cows. This is a significant achievement, given that foot-and-mouth disease severely affects animals but poses no risk to humans. Further studies are underway to approve the vaccine.
Sources
Cercetătorii germani au testat cu succes un vaccin pe bază de ARNm împotriva febrei aftoase
Cercetătorii germani au testat cu succes un vaccin pe bază de ARNm împotriva febrei aftoase
Cercetătorii germani au testat cu succes un vaccin împotriva febrei aftoase. Acesta folosește tehnologia ARNm
Cercetătorii germani au testat cu succes un vaccin pe bază de ARNm împotriva febrei aftoase
Latest News
22:57
AI companies and chipmakers lose more than $1 trillion amid concerns over financing
22:46
Salvamont rescuers are warning drivers and tourists after snow began falling on the Transfăgărășan and in Poiana Brașov
22:39
The Niculescu Government proposes exempting mothers from paying CASS and maintaining the child-rearing allowance after returning to work
22:25
Niculescu Government targets a deficit below 3% of GDP by 2030 / Spending, tax evasion and revenue collection are priorities
21:55
The government proposed by Luca Niculescu wants to attract a strategic investor to TAROM in 2027, including for a majority stake
See more news